Skip to main content

Walleye Capital LLC

Position in ARCT — Arcturus Therapeutics Holdings Inc.

CIK 1758720 NEW YORK, NY

Position in ARCT

as of Jun 30, 2026 · filed Aug 3, 2026
Position Value
$129,850
+$129,844 QoQ
Shares Held
19,323
+1932200.0% QoQ
Ownership
0.068%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#69
of 133 holders
Holding Since
Mar 2021
9 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ARCT Over Time

Shares Held

Position Value (USD)

Derivatives in ARCT

reported options exposure · as of Jun 30, 2026
CallValue
$75,936
CallShares
11,300
PutValue
$10,080
PutShares
1,500

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Walleye Capital LLC holds $328,656,270 across 126 Biotechnology names. ARCT ranks #100 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in ARCT

Export CSV
20 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $129,850 19,323
2026-06-30 $10,080 1,500
2026-06-30 $75,936 11,300
2025-12-31 $68,656 11,200
2025-12-31 $24,520 4,000
2025-12-31 $6 1
2025-09-30 $320,682 17,400
2025-09-30 $105,051 5,700
2025-06-30 $54,642 4,200
2025-06-30 $210,762 16,200
2024-12-31 $1,697 100
2024-12-31 $1,697 100
2024-12-31 $176,369 10,393
2024-06-30 $163,023 6,695
2024-06-30 $357,945 14,700
2024-06-30 $258,110 10,600
2024-03-31 $246,521 7,300
2024-03-31 $74,294 2,200
2022-06-30 $1,069,973 67,978
2021-03-31 $353,817 8,567